Moxifloxacin Hydrochloride Dealers in Mumbai

• Purity: 99%
• Cas Number: 186826-86-8
• Mol. Formula: C21H25CLFN3O4
• Mol.weight: 437.89
• Standard: Offered of Pharmaceutical Grade BP/USP/EP
• Packing: Offered in Export Worthy Packing of 25 Kilos or as per Our Customer Requirements
• Supplied By: UMA Brothers, India

Moxifloxacin Hydrochloride Is The Hydrochloride Salt Preparation Of Moxifloxacin, An 8-Methoxy-Fluoroquinone Compound With Broad-Spectrum Bactericidal Activity Against Gram-Positive & Gram-Negative Strains. 8-Methoxy-Fluoroquinones Are Described To Inhibit The Activities Of Topo Ii (DNA Gyrase) & Topoisomerase Iv. The 8-Methoxy Group Of Moxifloxacin Is Suggested To Confer A Lowered Propensity For Resistance Development As Compared To Other C-8 Substituted Quinolones, & Moxifloxacin Demonstrates Potent Activity Against Wild-Type And First-Step Gyrase- & Topoisomerase Iv-Resistant Mutants. Moxifloxacin Shows Activity Against Methicillin-Susceptible Staphy Lococci, Penicillin-Susceptible And Penicillin-Resistant Pneumococci, Penicillin-Susceptible & Penicillin-Resistant Viridans Group streptococci, Group A streptococci, m. Catarrhalis, & H. Influenzae in Vitro.Synonyms : 7-[(4as,7as)-1,2,3,4,4a,5,7,7a-Octahydropyrrolo[3,4-B]Pyridin-6-Yl]-1-Cyclopropyl-6-Fluoro-8-Methoxy-4-Oxoquinoline-3-Carboxylic Acid;Hydrochloride.Moxifloxacin Hydrochloride is a Slightly Yellow to Yellow Crystalline Substance. It is Sparingly Soluble in Water (24 Mg/ml), Dmso (88 Mg/ml At 25 °c), and Ethanol (<1 Mg/ml At 25 °c) with Melting Ran.

• SLIGHTLY YELLOW TO YELLOW CRYSTALLINE SUBSTANCE: SLIGHTLY YELLOW TO YELLOW CRYSTALLINE SUBSTANCE

Moxifloxacin hydrochloride is the hydrochloride salt preparation of moxifloxacin, an 8-methoxy-fluoroquinone compound with broad-spectrum bactericidal activity against gram-positive & gram-negative strains. 8-methoxy-fluoroquinones are described to inhibit the activities of topo ii (dna gyrase) & topoisomerase iv. The 8-methoxy group of moxifloxacin is suggested to confer a lowered propensity for resistance development as compared to other c-8 substituted quinolones, & moxifloxacin demonstrates potent activity against wild-type and first-step gyrase- & topoisomerase iv-resistant mutants. Moxifloxacin shows activity against methicillin-susceptible staphy lococci, penicillin-susceptible and penicillin-resistant pneumococci, penicillin-susceptible & penicillin-resistant viridans group streptococci, group a streptococci, m. Catarrhalis, & h. Influenzae in vitro.